Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Considering the importance of a person’s level of neutralizing antibody as an acceptable person to do certain work or to be of acceptable international traveling status , AXIM seems to be under the radar.
One possible threat to this potential value for AXIM is if there are other companies with similar technology that is superior or is in direct competition with ImmunoPass.
There is rarely a case where we investors have perfect knowledge of the capability of our competition and what they have already or will in the future achieve.
If we were indeed scammed now would be the time that we shareholders get to figure that out for real.
I believe the data had shown that there was a very low percentage short interest held at the time. The short interest data is stored at the OTC website. I do not think that the recent run to 7 cents could have been a short squeeze but as always it is certainly possible that I could be wrong about that.
The LA Hub , 2 locations, has been delayed since the original announcement it seems to me. It was some time in 2020 that we would be open. What is the reason SGMD has given for the delay?
What might be the reason for a delay or failure to acquire the intended 70% of BudCars? Who is the current owner of BudCars? What is his or her relationship with the SGMD CEO Jimmy Chan?
Is the option to purchase agreement for purchase of 70% of BudCars online and available for inspection? The fine print could be important to read and inspect. This could affect a nationwide expansion and whether SGMD would have a 70% ownership of BudCars nationwide.
What would be the barrier for entry for competition who could erode away the current large gross profit margins enjoyed by BudCars (65% or more if I remember correctly) on door to door cannabis delivery?
If you read our PRs for SGMD they read as though SGMD owned BudCars, which it does not. It has a 40% interest. I thought there would be securities laws that would protect investors or speculators from misleading or factually incorrect information being put out in PRs as if they were true and complete.
Thanks for any insights here.
There is no PXLIF IHUB functional message board. I will post my question here for that reason. Can an american buy PXLIF on the Israeli stock market? Is that what you did Milo?
When will SGMD own a majority interest in BudCars? Is LA location now open and running?
News Today. Canntab Therapeutics has been issued a second patent for immediate release cannabinol tablet. See news at OTC website.
OTCBB for PXLIF. Price is $0.832. Warning: Only Unsolicited Quotes. There is no bid and no ask. What to make of this?
Thanks MJM. PXLIF is the ticker symbol. There seems to be an existing equity for Panaxia but the price is listed as zero and there is no trading volume.
I will go to the OTC website
Perhaps this is a new listing.
Couldn’t CTABF strengthen the dosage of tablets for sale outside of Canada?
Cheers and congratulations to all who had that obscure cable TV company mentioned by a known traveler that will not be named.
Perhaps AXIM could be mentioned on the Reddit Stock Advice Board? I would never do that myself, but imagine the possible effect.
What is the meaning of forensic vote audits as Blue Sky has discussed? Thanks.
Thanks RpK6.
I was looking for just this sort of thing. Current short interest is as of 1/15/21 around 44,800 shares held short. Average recent daily share volume traded is 193 million. That volume shot up recently. Usually average daily volume is much lower for VDRM up to now.
The calculation for percentage of daily traded shares held short should come out as 0.0227% which would seem to me to be a very small amount of shares that are currently, as of 1/15/21, being held short for VDRM.
I looked at the OTC website in the past but did not see that this short interest data was there and being reported for pink sheet stocks. Maybe it has been there all along?
What if Immunopass were to become a standard requirement to board a flight or to enter a foreign country?
I guess one problem would be that you could have the virus, be expressing neutralizing antibodies and perhaps still be infectious? I don’t know.
Maybe it would be in combination with an antigen reactivity test for presence of Coronavirus -19 and the many new variants that will required for travel. Showing a certificate of vaccination might not be enough. The Chinese vaccine is only 50% effective.
Monitoring the outcomes and effectiveness of vaccines may make good sense and Immunopass could be complete on its own for this one indication. When you fail the Immunopass test you will know that it is time for a booster shot of vaccine.
Is there an immunologist on this board who might shed some light on these or related issues? Thanks.
That was an incredibly useful post by Civ5 aka Mark who seems to be a securities attorney. Firstly, is DGF properly registered with FINRA? Does anybody know? Does anybody know where to look that up?
Secondly, if DGF was reluctant to open up the books to OWCP as Ziv Turner reported to MJMilo who then reported it to us, then perhaps they would be reluctant to have the SEC scrutinize their finances and business practices to the nth degree as well. I do not know.
Thirdly somebody has got to let our CEO Ziv Turner know about this last recent post by Civ5/Mark. I do not think that Ziv reads this board. Maybe Milo can inform him.
Thanks to MJMilo for discussing this stock on the OWCP board three weeks ago when CATV was at $0.0012.
It would seem to me that a name change for the company should be considered since the company has nothing to do with cable television or perhaps very little.
Would DGF agree to a $5 million pay off and then go away and not hinder OWCP any longer? That would be great. How much money did DGF get back so far? Can the bankruptcy judge force DGF to accept a payoff?
We are up 100% in a month. Usually there would be some sort of news. Is there news?
Has anybody here tried Vyleesi? How did it work for you?
Can someone explain the special nature of our neutralizing antibody test versus or in comparison with the IgG antibody tests that are already for sale on the market. Is ours an IgG test? Other tests are 15 minutes at home and our test is 10 minutes at home.
Our neutralizing antibody test is purported to be something different from the competition. It is for antibodies that neutralize the Covid-19 virus and I think it had to do with biochemically reacting specifically with the spike protein of the coronavirus. Similar to what our mask invention does.
The question I have is to explain this distinction from the competition’s product in layman’s terms that shows why the AXIM test is a superior test to what the competition is currently offering or will offer in the near future, if that is possible. Thanks.
At he same time as the run up in price there was an article published on TipRanks.com that was bullish. It was at 1:17 pm eastern time today.
The author is Michael Marcus. He sees a price target of 2 or 3 dollars which is a lot higher than 42 cents where it was when he posted his positive statements. He said that the Cannacord analyst also sees real potential for PTN with a price target of $3. That last part is not news as that analyst has been long for years.
I do not see how a fairly unknown person could have an opinion that when stated publicly could have such a dramatic effect on trading.
It could just be a coincidence, but it seems unlikely for such a punctuated change in trading sentiment to occur. Something would have to cause it.
He also talked about the Covid-19 trials starting for one of its clinical trials drugs. That right there might be a big part of the price appreciation, but this last catalyst here is also not breaking news. The Covid-19 trials were announced perhaps months ago.
Perhaps early Covid-19 trial results got leaked, but that is not in the Michael Marcus report.
Whatever the reason, I am glad to see this thing PTN move and show some signs of life. I will hold for at least $2.
Is there a special grant of money received from the federal government when doing Covid-19 patient trials? PTN has significant amounts of money, around $80 million cash, but it would be nice to receive additional funding.
This bit of news of a PTN Covid project seems to be completely under the radar or dismissed without review as not being an important material matter.
There appears to be a low level of faith by investors in the PTN management at this point in time.
Criminal usury is a class E felony in New York. If the offender has a history of criminal activity or of running a “scheme”, then it gets worse and more stringent , up to a class C felony and up to 15 years in prison. Is this correct? Is this corporate to corporate?
It is when the usurious offender files a case to collect that they can be charged. DGF may just decide not to file a claim on the OWCP assets.
DGF’s unwillingness to open up the books for inspection could reveal a history of some sort of corruption. This is just pure speculation on my part and in no way should it be misconstrued as any sort of attempt to defame anyone.
IG does seem to be somewhat wrong about New York usury law. There is a real sense of teeth in the law. I had no idea.
Does anybody have access to the Israeli corporate to corporate usury law. Is it Israeli law that counts for us?
DED results showed efficacy in moderate to severe dry eye, but not so much in mild dry eye. Phase 3 will now focus on those moderate to severe DED patients. I saw that as a positive news item, but the market sold PTN after the announcement.
What is the next news item to look for regarding Vyleesi marketing and sales? Do female patients ever report their experiences on “The View” or on “Oprah” on TV? If not, why not? This is how word of mouth gets going and snowballs.
The updated website is a sort of “proof of life” bit of information. What other evidence do we have that VDRM is an active and legitimate business and not a shell company share selling scheme type of scam?
Dr. Otiko does not seem to hire promoters and board posters the way that Jimmy Chan at SGMD does. If it was all a scam to sell shares I would expect to have seen paid promotion here.
When is the LA Hub for BudCars opening? Has that been delayed from the original announcement perhaps 6 months ago? When was the last annual shareholder meeting for SGMD? Thanks.
AXIM has a neutralizing antibody test that is at home and takes 10 minutes. This should be big news. Instead it is little news, but still good news. This makes me wonder about the competition out there to produce this product.
I did see that the production of product had started at Empower Therapeutics Corp perhaps two months ago when they first filled for an EUA. That means that by now they might have an abundant supply of product already manufactured and ready to be delivered. That would be nice.
Now that they have successfully done testing it is my guess that perhaps the EUA can be issued. Sales would then be allowed to occur.
The vaccine manufacturers or the FDA may want to track the persistence of neutralizing antibody to know when a booster shot may be needed. Individuals may want to know for themselves or family. Airlines may want to know in order to fly. Professional athletes, health workers, front line responders etc. may want to keep track periodically.
It’s the unknown level of competition that worries me or that the test does not really work as well as advertised.
CUR used to have a drug in clinical trials called NSI-189. It was a small molecule that does easily cross the blood brain barrier. It has been shown anatomically that it would cause neural growth in the hippocampus. It did show cognitive benefits for patients but missed the mood related psychological endpoints in a depression trial.
I thought that the drug still had potential. I do not however see any recent news about NSI-189. Does any one know anything that they could share about the current status or the potential clinical benefits of NSI-189? Thanks.
IG said that in the USA there are no usury law protections involving business loans. The Bankruptcy Court we are using however is in Israel. Perhaps in Israel there is a protection from usury. Perhaps if DGF is not willing to open their books due to corruption, then the Israeli court will not play their game and will not act in their favor.
If there is no news over the next 60 to 90 days then the OWCP stock price would be expected to decline significantly over this time period. In most instances the common shareholders do not do well with a bankruptcy.
Does the OWCP ticker change with the company in bankruptcy?
Wow Milo great reporting by you. Thanks to you and to Ziv and to Ziv’s lawyer. Once DGF is disposed of it would be like shackles being removed. This stock is legendary in the level of drama and intrigue.
Thanks Millstone. Great article. If things go well for LPCN in the Clarus jury trial or they settle before the trial, then LPCN could see revenues or a deal happen sooner than March 2022.
NASH also looks like the trials might show that TRT does indeed work for nonalcoholic fatty liver disease. Those are two shots on goal. The once a day TRT oral pill would just be icing on the cake.
I sound like a pumper. I do realize that dilution is always a risk on the horizon.
If preferred shares have priority over common shares, is it still somehow possible to “get rid”of DGF and have common shareholders remain relatively unimpaired with their purchased shares not being canceled?
If DGF is “unsecured” does that mean that DGF cannot or will not be granted ownership of the OWCP intellectual property assets by a court, such as patents that have been awarded to OWCP?
IG seemed fairly certain that shareholders of OWCP are now officially soon to be toast.
The new website does look nicer. Does Dr. Otiko do the ViaDerma website design himself? I am glad to see that some sorts of efforts are being put forward apparently.
So then is this really the end? Is there no longer any chance that things could turn out OK for shareholders?
What is it that would cause 50+ million in share volume suddenly to happen when there is no news? HB says “trader groups.” Wouldn’t a trader group also be on this board pumping and spamming like they have done on here several times quite successfully in the past couple of years?
Perhaps as an alternate strategy the trader group buys a big volume of shares and then hopes that technical algorithms get triggered. Then they get out really quick with the pop to 0.0027. Maybe AI is used to implement the stock price manipulation and determine the short term top.
Or perhaps some sort of news is truly out there on the horizon and somebody does indeed know something that we as investors know nothing about yet.
If there is a deal, perhaps that might be the reason that Ziv has been so quiet lately, not even responding to MJMilo’s queries. Ziv would need to be silent until there was a chance to do an official PR abiding by a fair disclosure.
Is DFG going to help OWCP with the fee required to be paid for the European Patent Office to issue our patent? Other patent activity continues but who is paying the patent attorneys? What are the odds of getting a sublingual tablet patent issued?
Canntab Therapeutics begins delivery on a $1.3 million (Canadian) order to Medipharm Labs Corp. This might be why the stock price is up a bit in the past few days. Larry Latowsky (CEO) says that 2 SKUs of a total of 5 SKUs are already shipping. The products are pressed tablets and caplets. Terpenes are a listed and measured ingredient along with the standard THC and CBD. These terpenes might be a unique and differentiating aspect to Canntab products.
The news is listed on the OTC website Dec 1, 2020
82 million shares traded today does equal the necessary new voters needed if they do another vote about increasing the authorized share count. Why wouldn’t Ziv do another vote?
What is the most proximate catalyst for AXIM? Thanks.